Amperometric magnetoimmunoassay for the determination of lipoprotein(a)

AbstractA highly sensitive amperometric magnetoimmunoassay for rapid determination of lipoprotein(a) (Lp(a)), an important predictor of cardiovascular disease risk, in human serum, is described. It uses a sandwich configuration involving selective capture antibody [antiLp(a)] and biotinylated detector antibody [biotin-antiLp(a)], and a streptavidin-HRP conjugate on carboxy-modified magnetic beads (HOOC-MBs). The resulting MBs bearing the sandwiched immunoconjugates were captured by a magnet placed under the working electrode surface of a disposable screen-printed carbon electrode and the extent of the affinity reaction was monitored amperometrically at −0.20 V (vs a silver pseudo-reference electrode) in the presence of hydroquinone as an electron transfer mediator and upon addition of H2O2 as the enzyme substrate. The method exhibited a wide linear response range (from 0.01 to 0.5 μg mL−1), a detection limit of 4 ng mL−1, and an excellent selectivity over other serum components. The utility of the immunoassay was demonstrated by analyzing a reference serum containing a certified quantity of Lp(a). The performance of this magnetoimmunoassay compares favorably to that of an integrated amperometric immunoassay described earlier. Graphical AbstractThe article describes the first disposable and highly sensitive amperometric magnetoimmunoassay for lipoprotein(a), an important predictor of cardiovascular disease risk, in human serum. It is  based on a sandwich configuration involving selective capture antibody and biotinylated secondary antibody, and a streptavidin-HRP conjugate on magnetic beads.

[1]  G. Kostner,et al.  Preparation of a stable fresh frozen primary lipoprotein[a] (Lp[a]) standard. , 1999, Journal of lipid research.

[2]  S. Campuzano,et al.  Amperometric Magnetoimmunosensors for Direct Determination of D‐Dimer in Human Serum , 2012 .

[3]  M. Marco,et al.  Ultrasensitive amperometric magnetoimmunosensor for human C-reactive protein quantification in serum , 2013 .

[4]  Berta Esteban-Fernández de Ávila,et al.  Disposable amperometric magnetoimmunosensor for the sensitive detection of the cardiac biomarker amino-terminal pro-B-type natriuretic peptide in human serum. , 2013, Analytica chimica acta.

[5]  María Pedrero,et al.  Disposable magnetic DNA sensors for the determination at the attomolar level of a specific enterobacteriaceae family gene. , 2008, Analytical chemistry.

[6]  N. Milton,et al.  Lipoprotein (a) does not participate in the early acute phase response to training or extreme physical activity and is unlikely to enhance any associated immediate cardiovascular risk. , 2002, Journal of clinical pathology.

[7]  L. Sorell,et al.  A sandwich ELISA based on anti-apo(a) and anti-apo B monoclonal antibodies for lipoprotein(a) measurement. , 1995, Clinica chimica acta; international journal of clinical chemistry.

[8]  M. Marco,et al.  Lipoprotein(a) determination in human serum using a nitrilotriacetic acid derivative immunosensing scaffold on disposable electrodes , 2014, Analytical and Bioanalytical Chemistry.

[9]  K. Bone,et al.  Principles and Practice of Phytotherapy: Modern Herbal Medicine , 1999 .

[10]  Susana Campuzano,et al.  Disposable amperometric magneto-immunosensor for direct detection of tetracyclines antibiotics residues in milk. , 2012, Analytica chimica acta.

[11]  V. Salomaa,et al.  Lipoprotein(a) and the risk of cardiovascular disease in the European population: results from the BiomarCaRE consortium , 2017, European heart journal.

[12]  E. Steinhagen-Thiessen,et al.  A Systematic Literature Review of the Association of Lipoprotein(a) and Autoimmune Diseases and Atherosclerosis , 2012, International journal of rheumatology.

[13]  J. Danesh,et al.  Risk factors: Lipoprotein(a) and coronary disease—moving closer to causality , 2009, Nature Reviews Cardiology.

[14]  R. Collins,et al.  Genetic variants associated with Lp(a) lipoprotein level and coronary disease. , 2009, The New England journal of medicine.

[15]  Li Fu,et al.  Development of new enzyme-linked immunosorbent assay for oxidized lipoprotein(a) by using purified human oxidized lipoprotein(a) autoantibodies as capture antibody. , 2007, Clinica chimica acta; international journal of clinical chemistry.

[16]  K. Bone,et al.  Principles and Practice of Phytotherapy Modern Herbal Medicine: E-Book , 2015 .

[17]  G. Crepaldi,et al.  Comparison of lipoprotein(a) assay methods in serum and in a plasminogen-free fraction. , 1993, Clinica chimica acta; international journal of clinical chemistry.

[18]  Chunni Zhang,et al.  Detection of IgG-bound lipoprotein(a) immune complexes in patients with coronary heart disease. , 2003, Clinica chimica acta; international journal of clinical chemistry.

[19]  X. Yao,et al.  Quantitation of plasminogen epitopes of serum lipoprotein(a) by sandwich enzyme linked immunosorbent assay. , 1997, Clinica chimica acta; international journal of clinical chemistry.

[20]  B. Nordestgaard,et al.  Extreme lipoprotein(a) levels and improved cardiovascular risk prediction. , 2013, Journal of the American College of Cardiology.

[21]  J. Ordovás,et al.  Lipoprotein(a) levels in familial hypercholesterolemia: an important predictor of cardiovascular disease independent of the type of LDL receptor mutation. , 2014, Journal of the American College of Cardiology.